The Patent Finder

Progenitor, Inc.

Also on record
Records under this name other than patents Progenitor, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Progenitor, Inc.

PatentTitleStatus Expires Confidence
US 6,228,594Method for determining the presence or absence of a hereditary hemochromatosis gene mutation
Formerly held
Term ended
Term ended Feb 14, 2020 · From the USPTO record
Term endedTerm ended Feb 14, 2020From the USPTO record
US 6,284,732Peptides and peptide analogues designed from HFE protein and their uses in the treatment of iron overload diseases
Formerly held
Term ended
Term ended Dec 18, 2018 · From the USPTO record
Term endedTerm ended Dec 18, 2018From the USPTO record
US 6,391,852Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
Formerly held
Term ended
Term ended Jun 13, 2017 · From the USPTO record
Term endedTerm ended Jun 13, 2017From the USPTO record
US 6,140,305Hereditary hemochromatosis gene products
Formerly held
Term ended
Term ended Apr 4, 2017 · From the USPTO record
Term endedTerm ended Apr 4, 2017From the USPTO record
US 6,025,130Hereditary hemochromatosis gene
Formerly held
Term ended
Term ended May 23, 2016 · From the USPTO record
Term endedTerm ended May 23, 2016From the USPTO record
US 6,849,399Methods and compositions for diagnosis and treatment of iron misregulation diseases
Formerly held
Term ended
Ended no later than May 23, 2016 · From the USPTO record
Term endedEnded no later than May 23, 2016From the USPTO record
US 7,026,116Polymorphisms in the region of the human hemochromatosis gene
Formerly held
Term ended
Term ended Apr 4, 2016 · From the USPTO record
Term endedTerm ended Apr 4, 2016From the USPTO record
US 7,078,513Plasmids comprising nucleic acids from the hereditary hemochromatosis gene
Formerly held
Term ended
Ended no later than Apr 4, 2016 · From the USPTO record
Term endedEnded no later than Apr 4, 2016From the USPTO record
US 6,355,237Methods for using the obese gene and its gene product to stimulate hematopoietic development
Formerly held
Term ended
Term ended Sep 14, 2014 · From the USPTO record
Term endedTerm ended Sep 14, 2014From the USPTO record
US 6,670,321Prevention and treatment for retinal ischemia and edema
Formerly held
Lapsed on the fee record
Ended Dec 30, 2011 · From the USPTO record
Lapsed on the fee recordEnded Dec 30, 2011From the USPTO record
10 of 27 patents shown.
Pro members see all 27.
Pro members: see all 27 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited